HEALTH
Adding temozolomide to radiation therapy improves survival in adult patients with slow-growing brain tumor, trial finds
![Adding temozolomide to radiation therapy improves survival in adult patients with slow-growing brain tumor, trial finds](https://connecticutnewspress.com/wp-content/uploads/2024/11/27255-adding-temozolomide-to-radiation-therapy-improves-survival-in-adult-patients-with-slow-growing-brain-tumor-trial-finds.jpg)
Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas. The randomized phase 3 trial E3F05 by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) tested whether combined therapy using temozolomide alongside radiation therapy is more effective than radiation therapy alone in these patients…